Upton, Dannielle H; Liu, Jie; George, Sandra M; Valvi, Santosh; Ung, Caitlin; Rayner, Benjamin S; Gopalakrishnan, Anjana; Pandher, Ruby; Khan, Aaminah; Venkat, Pooja; Mayoh, Chelsea; Holliday, Holly; Yeung, Nicole; Nguyen, Hieu; Franshaw, Laura; Ehteda, Anahid; Shen, Han; Farruggia, Giovanna; Orienti, Isabella; Reynolds, C Patrick; Tsoli, Maria; Ziegler, David S, High-throughput in vitro drug screening and in vivo studies identify fenretinide as a brain-penetrant DMG therapeutic, «NEURO-ONCOLOGY», 2025, Non conosciuto, pp. N/A - N/A [articolo]
De Angelis, M. L.; Francescangeli, F.; Arico, E.; Verachi, P.; Zucchetti, M.; Matteo, C.; Petricci, E.; Pilozzi, E.; Orienti, I.; Boe, A.; Eramo, A.; Rossi, R.; Corati, T.; Macchia, D.; Pacca, A. M.; Zeuner, A.; Baiocchi, M., A nanoencapsulated oral formulation of fenretinide promotes local and metastatic breast cancer dormancy in HER2/neu transgenic mice, «JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH», 2024, 43, Article number: 296, pp. 43 - 62 [articolo]Open Access
Anconelli, Lorenzo; Farioli, Francesca; Lodeserto, Pietro; Andreadi, Aikaterini; Borsetti, Francesca; Voltattorni, Manuela; Galassi, Lucrezia; Rossi, Martina; Farruggia, Giovanna; Blasi, Paolo; Orienti, Isabella, Antiproliferative and Morphological Effects of Fenretinide Lipid Nanosystems in Colon Adenocarcinoma Cells, «PHARMACEUTICS», 2024, 16, Article number: 1421, pp. 1 - 17 [articolo]Open Access
Farruggia G.; Anconelli L.; Galassi L.; Voltattorni M.; Rossi M.; Lodeserto P.; Blasi P.; Orienti I., Nano-fenretinide demonstrates remarkable activity in acute promyeloid leukemia cells, «SCIENTIFIC REPORTS», 2024, 14, Article number: 13737, pp. 1 - 12 [articolo]Open Access
Matteo, C.; Orienti, I.; Eramo, A.; Zeuner, A.; Ferrari, M.; Passoni, A.; Bagnati, R.; Ponzo, M.; Bello, E.; Zucchetti, M.; Frapolli, R., Validated LC-MS/MS Assay for the Quantitative Determination of Fenretinide in Plasma and Tumor and Its Application in a Pharmacokinetic Study in Mice of a Novel Oral Nanoformulation of Fenretinide, «PHARMACEUTICS», 2024, 16, pp. 387 - 401 [articolo]
Lucrezia Galassi; Martina Rossi; Pietro Lodeserto; Monia Lenzi; Francesca Borsetti; Manuela Voltattorni; Giovanna Farruggia; Paolo Blasi; Isabella Orienti, Naxitamab Activity in Neuroblastoma Cells Is Enhanced by Nanofenretinide and Nanospermidine, «PHARMACEUTICS», 2023, 15, Article number: 648, pp. 1 - 19 [articolo]Open Access
Potenza RL, Lodeserto P, Orienti I, Fenretinide in Cancer and Neurological Disease: A Two-Face Janus Molecule, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2022, 23, pp. 7426 - 7444 [articolo]Open Access
Lodeserto, Pietro; Rossi, Martina; Blasi, Paolo; Farruggia, Giovanna; Orienti, Isabella, Nanospermidine in Combination with Nanofenretinide Induces Cell Death in Neuroblastoma Cell Lines, «PHARMACEUTICS», 2022, 14, Article number: 1215, pp. 1 - 21 [articolo]Open Access
Orienti, I; Armida, M; Dobrowolny, G; Pepponi, R; Sollazzini, G; Pezzola, A; Casola, I; Musarò, A; Popoli, P; Potenza, Rl., Fenretinide Beneficial Effects on Amyotrophic Lateral Sclerosis-associated SOD1 G93A Mutant Protein Toxicity: In Vitro and In Vivo Evidences, «NEUROSCIENCE», 2021, 473, pp. 1 - 12 [articolo]
Dannielle Upton, Santosh Valvi, Jie Liu, Nicole Yeung, Sandra George, Caitlin Ung, Aaminah Khan, Laura Franshaw, Anahid Ehteda, Han Shen, Isabella Orienti, Giovanna Farruggia, Patrick Reynolds, Maria Tsoli, and David Ziegler, RARE-08. POTENTIAL NEW THERAPIES FOR DIFFUSE INTRINSIC PONTINE GLIOMAS IDENTIFIED THROUGH HIGH THROUGHPUT DRUG SCREENING, «NEURO-ONCOLOGY», 2021, 23, pp. i42 - i42 [abstract]
Dannielle Upton, Santosh Valvi, Jie Liu, Nicole Yeung, Sandra George, Caitlin Ung, Aaminah Khan, Laura Franshaw, Anahid Ehteda, Han Shen, Isabella Orienti, Giovanna Farruggia, Christa Nath, Patrick Reynolds, Maria Tsoli, David Ziegler, DIPG-07. HIGH THROUGHPUT DRUG SCREENING IDENTIFIES POTENTIAL NEW THERAPIES FOR DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPGs), «NEURO-ONCOLOGY», 2020, 22, pp. iii288 - iii288 [abstract]
Orienti I.; Farruggia G.; Nguyen F.; Guan P.; Calonghi N.; Kolla V.; Chorny M.; Brodeur G.M., Nanomicellar Lenalidomide-Fenretinide Combination Suppresses Tumor Growth in an MYCN Amplified Neuroblastoma Tumor, «INTERNATIONAL JOURNAL OF NANOMEDICINE», 2020, 15, pp. 6873 - 6886 [articolo]Open Access
Orienti I.; Gentilomi G.A.; Farruggia G., Pulmonary delivery of fenretinide: A possible adjuvant treatment in COVID-19, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2020, 21, Article number: 3812, pp. 3812 - 3828 [articolo]Open Access
Orienti I.; Cripe T.P.; Currier M.A.; Cavallari C.; Teti G.; Falconi M., A cationic nanomicellar complex of the quaternary amphiphilic amine rc16+ with fenretinide as a new multitasking system for antitumor therapy, «CURRENT DRUG DELIVERY», 2019, 16, pp. 807 - 817 [articolo]
Orienti I.; Francescangeli F.; De Angelis M.L.; Fecchi K.; Bongiorno-Borbone L.; Signore M.; Peschiaroli A.; Boe A.; Bruselles A.; Costantino A.; Eramo A.; Salvati V.; Sette G.; Contavalli P.; Zolla L.; Oki T.; Kitamura T.; Spada M.; Giuliani A.; Baiocchi M.; La Torre F.; Melino G.; Tartaglia M.; De Maria R.; Zeuner A., A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors, «CELL DEATH & DISEASE», 2019, 10, Article number: 529, pp. 529 - 548 [articolo]Open Access
